Participants generally agree that HOMA-IR and HOMA-B are associated with diabetes risk, but some posts highlight their limited predictive power, using phrases like 'not reliable alone' and 'indicate risk but shouldn’t be sole criteria.' The tone is analytical yet cautious, reflecting both interest and skepticism toward the practical application of these research findings.
AgreementModerate agreement
Most discussions acknowledge the findings, with some suggesting the markers are useful but imperfect predictors.
InterestHigh interest
Posts show high curiosity, especially about the practical implications of using these markers in diagnosis.
EngagementModerate engagement
There is some participation with references to medical implications and questioning of predictive reliability, though not deeply technical.
ImpactModerate impact
The discussions indicate a moderate influence on thoughts about diabetes risk assessment, recognizing these markers' potential but also their limitations.
Abstract in brief
The study found that increased levels of HOMAIR are associated with a higher risk of developing various diabetes and prediabetes subtypes, while higher HOMAB levels are linked to a higher risk of Impaired Glucose Tolerance (IGT) but are inversely related to Impaired Fasting Glucose (iIFG).
Despite these associations, neither HOMAIR nor HOMAB alone are reliable predictors for diabetes or prediabetes subtypes.
Overall, these markers can indicate risk but should not be used as sole criteria for predicting the development of diabetes or prediabetes.]
This video clarifies misconceptions about insulin resistance, emphasizing the importance of proper testing like the oral glucose tolerance test and cautioning against overreliance on HOMA-IR and QUICKI for routine…
This episode discusses the safety and efficacy of intermittent fasting for individuals with insulin-treated type 2 diabetes over 12 weeks, highlighting improved glycemic control, weight loss, and insulin reduction…
... переоценки наших результатов в других популяциях. https://bmcendocrdisord.biomedcentral.com/articles/10.1186/s12902-023-01291-9. [удалено]. • 2 ...